Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 116 | 2 | 105 | −9 |
| Shares | 24.4M | 192.9K | 24.0M | −265.8K (−1.1%) |
| Value | $166.5M | $1.31M | $116.5M | −$48.7M (−29.5%) |
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 177,891 | $865.0K | 0.00% |
| Gamco Investors, Inc. Et Al | 34,000 | $165.0K | 0.00% |
| Trexquant Investment LP | 32,867 | $160.0K | 0.01% |
| SG Americas Securities, LLC | 31,745 | $154.0K | 0.00% |
| HighVista Strategies LLC | 19,182 | $93.0K | 0.06% |
| Summit Global Investments | 18,600 | $90.0K | 0.01% |
| Jacobs Levy Equity Management, Inc | 16,185 | $79.0K | 0.00% |
| XTX Topco Ltd | 14,917 | $72.0K | 0.02% |
| Silverback Asset Management LLC | 986 | $5.00K | 0.00% |
| Ellevest, Inc. | 12 | $0 | 0.00% |
Sold out (19)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Essex Investment Management Co LLC | 178,850 | $1.22M |
| Driehaus Capital Management LLC | 164,500 | $1.12M |
| Engineers Gate Manager LP | 66,833 | $456.0K |
| ExodusPoint Capital Management, LP | 54,728 | $373.0K |
| Walleye Capital LLC | 40,718 | $278.0K |
| Los Angeles Capital Management LLC | 40,318 | $275.0K |
| Financial Engines Advisors L.L.C. | 40,000 | $273.0K |
| Cubist Systematic Strategies, LLC | 36,486 | $249.0K |
| Raymond James & Associates | 29,198 | $199.0K |
| HRT Financial LP | 28,388 | $193.0K |
| AQR Capital Management LLC | 26,115 | $178.0K |
| Atom Investors LP | 21,809 | $149.0K |
| Dynamic Technology Lab Private Ltd | 19,556 | $133.0K |
| Wolverine Trading, LLC | 15,391 | $105.0K |
| Walleye Trading LLC | 13,573 | $93.0K |
| Squarepoint Ops LLC | 12,406 | $85.0K |
| Pinz Capital Management, LP | 2,100 | $14.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 1,026 | $7.00K |
| Panagora Asset Management Inc | 575 | $4.00K |
Not filed for Q3 2021 yet (2)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 192,684 | $1.31M |
| Hoover Financial Advisors, Inc. | 200 | $1.00K |